PROMIS NEUROSCIENCES INC.

Profile

Company Names

PROMIS NEUROSCIENCES INC.
AMORFIX LIFE SCIENCES LTD

Addresses

SUITE 200, 1920 YONGE STREET, TORONTO, A6 M4S 3E2

3403 AMERICAN DRIVE, MISSISSAUGA, A6 L4V 1T4

Phone Numbers

416-847-6898

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$38,983,515.00

Number of Funding Rounds:

27
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
27
2022-10-11 
$7,472,282.00 
$10,066,823.00 
$2,594,541.00 
Equity 
26
2021-08-25 
$18,107,000.00 
$24,710,516.00 
$6,603,516.00 
Equity 
25
2021-03-22 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity, Debt 
24
2020-11-04 
$62,989.00 
$147,196.00 
$84,207.00 
Equity 
23
2019-11-15 
$99,999.00 
$273,333.00 
$173,334.00 
Equity 
22
2019-01-22 
$119,409.00 
$367,893.00 
$248,484.00 
Equity 
21
2018-04-19 
$1,735,160.00 
$2,845,659.00 
$1,110,499.00 
Equity 
20
2017-08-09 
$704,061.00 
$1,126,497.00 
$422,436.00 
Equity 
19
2017-02-22 
$44,694.00 
$75,517.00 
$30,823.00 
Equity 
18
2017-02-10 
$209,858.00 
$514,153.00 
$304,295.00 
Equity 
17
2016-09-09 
$206,310.00 
$296,635.00 
$90,325.00 
Equity 
16
2016-08-10 
$158,461.00 
$217,150.00 
$58,689.00 
Equity 
15
2016-03-29 
$460,000.00 
$460,000.00 
$0.00 
Equity 
14
2015-07-31 
$150,341.00 
$150,341.00 
$0.00 
Equity 
13
2015-07-06 
$434,164.00 
$434,164.00 
$0.00 
Equity 
12
2014-10-20 
$312,849.00 
$871,508.00 
$558,659.00 
Equity 
11
2014-02-28 
$379,233.00 
$988,713.00 
$609,480.00 
Equity 
10
2014-01-31 
$251,821.00 
$656,534.00 
$404,713.00 
Equity 
9
2014-01-14 
$256,082.00 
$667,642.00 
$411,560.00 
Equity 
8
2013-04-19 
$113,991.00 
$333,204.00 
$219,213.00 
Equity 
7
2013-04-04 
$128,218.00 
$374,790.00 
$246,572.00 
Equity 
6
2013-02-21 
$39,273.00 
$103,092.00 
$63,819.00 
Equity 
5
2012-05-14 
$20,000.00 
$40,000.00 
$20,000.00 
Equity 
4
2012-03-09 
$25,220.00 
$81,263.00 
$56,043.00 
Equity 
3
2012-01-17 
$100,474.00 
$323,748.00 
$223,274.00 
Equity 
2
2011-02-28 
$350,000.00 
$350,000.00 
$0.00 
Equity 
1
2009-04-29 
$41,626.00 
$73,646.00 
$32,020.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
 
ADAMS 
EXECUTIVE OFFICER, DIRECTOR
LARRY 
 
ALTSTIEL 
EXECUTIVE OFFICER
HANS 
 
BLACK 
DIRECTOR
NEIL 
 
CASHMAN 
EXECUTIVE OFFICER, DIRECTOR
MERYL 
 
CHERTOFF 
DIRECTOR
JANET 
 
CLENNETT 
EXECUTIVE OFFICER
WILLIAM 
 
COPELAND 
DIRECTOR
PHILLIPE 
 
COUILLARD 
DIRECTOR
GAIL 
M. 
FARFEL 
EXECUTIVE OFFICER
DANIEL E. 
 
GEFFKEN 
EXECUTIVE OFFICER
ELLIOT 
 
GOLDSTEIN 
DIRECTOR, EXECUTIVE OFFICER
RICHARD 
 
GREGORY 
DIRECTOR
ROBERT 
 
GUNDEL 
EXECUTIVE OFFICER, DIRECTOR
JOHANNE 
 
KAPLAN 
EXECUTIVE OFFICER
PATRICK 
 
KIRWIN 
DIRECTOR
PATRICK D. 
 
KIRWIN 
DIRECTOR
JAMES 
 
KUPIEC 
EXECUTIVE OFFICER
GAVIN 
T. 
MALENFANT 
EXECUTIVE OFFICER
JOSH 
 
MANDEL-BREHM 
DIRECTOR
AZIZ 
 
MEKOUAR 
DIRECTOR
STEVEN 
 
PLOTKIN 
EXECUTIVE OFFICER
JOHANNES 
 
ROTH 
DIRECTOR
JOHANNES 
MINHO 
ROTH 
DIRECTOR
MAGGIE 
 
SHAFMASTER 
DIRECTOR
MICHAEL 
 
SONNENREICH 
DIRECTOR
GRAHAM 
 
STRACHAN 
DIRECTOR
WALTER 
 
VON WARTBURG 
DIRECTOR
NEIL 
K. 
WARMA 
DIRECTOR
WARREN 
 
WHITEHEAD 
EXECUTIVE OFFICER, DIRECTOR
EUGENE 
 
WILLIAMS 
DIRECTOR, EXECUTIVE OFFICER
WILLIAM 
 
WYMAN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2022-10-11 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2021-08-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-22 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-28 
D
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2009-04-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CEROS FINANCIAL SERVICES, INC.
NONE
NONE
CEROS FINANCIAL SERVICES, INC.
NONE
NONE
NOBLE CAPITAL MARKETS, INC.
CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC.
CANACCORD GENUITY CORP.
NONE
NONE
NONE
CIBC WORLD MARKETS CORP.
630
NONE
NONE
ENCLAVE CAPITAL LLC